Search
for

    Research

    5 / 1000+ results
      Patient-Based Ratio Method for Permanent Zone Donor Area Calculation in Hair Transplant

      research Patient-Based Ratio Method for Permanent Zone Donor Area Calculation in Hair Transplant

      June 2024 in “Indian Journal of Plastic Surgery/Indian journal of plastic surgery”
      This study found that using a specific ratio method based on the patient's scalp measurements can effectively predict the dimensions of the permanent safe zone for hair transplants, particularly in early stages of androgenetic alopecia, potentially ensuring long-lasting transplant results.
      Male Pattern Androgenetic Alopecia in an Indian Context: A Perspective Study

      research Male pattern androgenetic alopecia in an Indian context: a perspective study

      28 citations , March 2007 in “Journal of The European Academy of Dermatology and Venereology”
      In this study, researchers found that the existing Norwood and Hamilton classifications for androgenetic alopecia in Indian males had significant limitations, with 18% of cases not fitting into existing pattern categories.
      A Clinical Study of Androgenetic Alopecia

      research A Clinical Study of Androgenetic Alopecia (V)

      4 citations , February 1995 in “Journal of Clinical Dermatology”
      This study observed an increasing trend of young patients with androgenetic alopecia visiting dermatologists, with genetic factors and abnormal androgen metabolism in the scalp contributing to its development.
      A Clinical Study of Androgenic Alopecia

      research A Clinical Study of Androgenic Alopecia (VII)

      1 citations , January 2009 in “Journal of Clinical Dermatology”
      This study reported an increase in female androgenic alopecia patients in their forties and found stress-related factors, particularly work tasks, associated with AGA in both male and female patients.

    Community Join

    5 / 1000+ results

      community GT20029 - Promising phase II results

       16 upvotes 2 years ago
      GT20029 showed significant hair growth and safety in phase II trials, with no adverse sexual events. Users are hopeful but concerned about future costs and systemic effects.

      community Breezula 6 Month Topline Phase III Results Released

       172 upvotes 9 months ago
      Breezula shows promising hair growth results, with up to 539% increase in hair count compared to placebo, and regulatory submissions are planned in the US and EU. Users are cautiously optimistic, noting the potential for Breezula to replace finasteride by targeting DHT without systemic effects.

      community Is there any new drug that looks promising ?

       26 upvotes 2 years ago
      The conversation discusses GT20029, a drug in Phase II trials that targets androgen receptors with minimal systemic effects, and TDM-105795, a growth stimulant with a different mechanism than minoxidil that may revive papilla stem cells. Both are potential new treatments for hair loss.

      community When did your regrowth level out?

      in Treatment  58 upvotes 10 months ago
      Hair regrowth typically levels out after several months of treatment with finasteride, dutasteride, and minoxidil, with many users experiencing stabilization rather than significant regrowth. Starting treatment early is crucial, as regrowth is rare beyond Norwood 3 without additional interventions like hair transplants.